ZIMMER BIOMET HOLDINGS INC (ZBH) Stock Price, Quote, News and Overview
NYSE:ZBH - New York Stock Exchange, Inc. - US98956P1021 - Common Stock - Currency: USD
ZBH Quote, Performance and Key Statistics
102.38
+0.56 (+0.55%)
The current stock price of ZBH is 102.38 USD. In the past month the price decreased by -9.12%. In the past year, price decreased by -15.85%.
ZBH Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.79 | 230.35B | ||
| ISRG | INTUITIVE SURGICAL INC | 69.3 | 189.75B | ||
| BSX | BOSTON SCIENTIFIC CORP | 38.86 | 155.20B | ||
| SYK | STRYKER CORP | 30.19 | 144.36B | ||
| MDT | MEDTRONIC PLC | 15.89 | 108.82B | ||
| BDX | BECTON DICKINSON AND CO | 11.98 | 48.46B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.1 | 44.47B | ||
| IDXX | IDEXX LABORATORIES INC | 41.39 | 38.24B | ||
| RMD | RESMED INC | 26.43 | 35.18B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.33 | 32.29B | ||
| DXCM | DEXCOM INC | 49.47 | 32.00B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.3 | 24.05B |
Related stock screener links
About ZBH
Company Profile
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The company is headquartered in Warsaw Indiana, Indiana and currently employs 17,000 full-time employees. The company went IPO on 2001-07-25. Its segments include Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific. The firm designs, manufactures and markets orthopedic reconstructive products; biologics, sports medicine, extremities and trauma (S.E.T.) products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and ankle, among others.
Company Info
ZIMMER BIOMET HOLDINGS INC
345 E Main St
Warsaw Indiana INDIANA 46580 US
CEO: Bryan Hanson
Employees: 17000
Phone: 15742676131
ZIMMER BIOMET HOLDINGS INC / ZBH FAQ
What is the stock price of ZIMMER BIOMET HOLDINGS INC today?
The current stock price of ZBH is 102.38 USD. The price increased by 0.55% in the last trading session.
What is the ticker symbol for ZIMMER BIOMET HOLDINGS INC stock?
The exchange symbol of ZIMMER BIOMET HOLDINGS INC is ZBH and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is ZBH stock listed?
ZBH stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for ZIMMER BIOMET HOLDINGS INC stock?
35 analysts have analysed ZBH and the average price target is 123.67 USD. This implies a price increase of 20.79% is expected in the next year compared to the current price of 102.38. Check the ZIMMER BIOMET HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ZIMMER BIOMET HOLDINGS INC worth?
ZIMMER BIOMET HOLDINGS INC (ZBH) has a market capitalization of 20.25B USD. This makes ZBH a Large Cap stock.
How many employees does ZIMMER BIOMET HOLDINGS INC have?
ZIMMER BIOMET HOLDINGS INC (ZBH) currently has 17000 employees.
What are the support and resistance levels for ZIMMER BIOMET HOLDINGS INC (ZBH) stock?
ZIMMER BIOMET HOLDINGS INC (ZBH) has a resistance level at 112.07. Check the full technical report for a detailed analysis of ZBH support and resistance levels.
Is ZIMMER BIOMET HOLDINGS INC (ZBH) expected to grow?
The Revenue of ZIMMER BIOMET HOLDINGS INC (ZBH) is expected to grow by 2.92% in the next year. Check the estimates tab for more information on the ZBH EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ZIMMER BIOMET HOLDINGS INC (ZBH) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ZBH, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ZBH, evaluating the profitability, health, valuation and growth aspects
- ZIMMER BIOMET HOLDINGS INC (ZBH) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ZIMMER BIOMET HOLDINGS INC (ZBH) Sales and EPS estimates to see what analysts future expectations are.
- ZIMMER BIOMET HOLDINGS INC (ZBH) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ZIMMER BIOMET HOLDINGS INC (ZBH) Insider and Institutional Ownership to learn about the owners and their transactions.
- ZIMMER BIOMET HOLDINGS INC (ZBH) Stock Chart to make your own analysis
- ZIMMER BIOMET HOLDINGS INC (ZBH) Latest news and press-releases to stay up to date.
Does ZIMMER BIOMET HOLDINGS INC (ZBH) stock pay dividends?
ZIMMER BIOMET HOLDINGS INC (ZBH) has a dividend yield of 0.94%. The yearly dividend amount is currently 0.97. Check the full fundamental report for a detailed analysis of ZBH dividend history, reliability and sustainability.
When does ZIMMER BIOMET HOLDINGS INC (ZBH) report earnings?
ZIMMER BIOMET HOLDINGS INC (ZBH) will report earnings on 2025-05-05, before the market open.
What is the Price/Earnings (PE) ratio of ZIMMER BIOMET HOLDINGS INC (ZBH)?
The PE ratio for ZIMMER BIOMET HOLDINGS INC (ZBH) is 12.8. This is based on the reported non-GAAP earnings per share of 8 and the current share price of 102.38 USD. Check the full fundamental report for a full analysis of the valuation metrics for ZBH.
What is the Short Interest ratio of ZIMMER BIOMET HOLDINGS INC (ZBH) stock?
The outstanding short interest for ZIMMER BIOMET HOLDINGS INC (ZBH) is 3.18% of its float. Check the ownership tab for more information on the ZBH short interest.
ZBH Technical Analysis
ZBH Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ZBH. While ZBH has a great profitability rating, there are some minor concerns on its financial health.
ZBH Financial Highlights
Over the last trailing twelve months ZBH reported a non-GAAP Earnings per Share(EPS) of 8. The EPS increased by 5.82% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 11.77% | ||
| ROA | 4.23% | ||
| ROE | 7.25% | ||
| Debt/Equity | 0.43 |
ZBH Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 70% to ZBH. The Buy consensus is the average rating of analysts ratings from 35 analysts.
For the next year, analysts expect an EPS growth of 3.68% and a revenue growth 2.92% for ZBH